All Topics

Celltrion has submitted a Marketing Authorization Application to the European Medicines Agency for CT-P55, its biosimilar candidate to Novartis' blockbuster drug COSENTYX. The application seeks approval across all European indications including multiple autoimmune conditions, following earlier regulatory filings in Canada and South Korea.

South Korea has unveiled an unprecedented $518 billion semiconductor cluster initiative, backed by Samsung and SK Group, targeting leadership across the entire AI technology stack from chips to robotics. The government is streamlining infrastructure and permitting while corporations provide the capital, compressing construction timelines from the 2040s to the mid-2030s. This coordinated industrial policy creates immediate legal, governance, and strategic implications for companies with Korean supply-chain e

South Korea has announced an expansion of its international anti-piracy efforts, strengthening cooperation with Interpol, US Homeland Security, and Southeast Asian authorities to combat transnational digital piracy operations. The initiative marks a strategic shift from website takedowns to targeting the individuals, infrastructure, and organized networks behind unauthorized content distribution, particularly as demand for Korean entertainment continues to grow globally.